To include your compound in the COVID-19 Resource Center, submit it here.

Immune Design raises $80M follow-on

On Oct. 24, immunotherapy company Immune Design Corp. (NASDAQ:IMDZ) raised $80

Read the full 115 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE